Quintrio
Home

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

NuSkin Enterprises, Inc.

NUS

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

Last trade $3.82
Day change -$0.115 (-2.93%)
Day range $3.78 – $3.93
Volume 319,211
Market cap $191M

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$191.3M
Price / earnings
—
Price / book
0.35×
Price / sales
0.14×
EV / sales
0.17×
EV / EBITDA
2.21×

Profitability

Earnings per share
-$4.81
Return on assets
-21.53%
Return on equity
-42.78%
Dividend yield
6.07%

Liquidity and leverage

Debt / equity
0.37×
Current ratio
2.04×
Quick ratio
1.22×
Cash ratio
0.7×

Cash flow

Price / cash flow
12.58×
Price / free cash flow
—
Free cash flow
-$26.26M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for NUS, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$311.01M$320.11M$320.61M$370.32M$364.21M$386.14M$364.49M$445.55M
Cost of revenue$108.84M$101.79M$106.15M$108.34M$107.49M$120.41M$117.53M$166.41M
Gross profit$202.17M$218.33M$214.46M$261.98M$256.72M$265.73M$246.96M$279.15M
Selling, general and administrative$197.08M$198.77M$208.6M$238.74M$235.08M$234.95M$231.75M$286.35M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$197.08M$277.64M$210.44M$238.74M$235.08M$234.95M$256.86M$332.23M
Operating income$5.09M-$59.32M$4.03M$23.24M$21.64M$30.78M-$9.9M-$53.08M
Interest expense-$3.5M-$3.32M-$4.25M-$3.99M-$4.15M-$2.53M-$3.28M-$5.86M
Income before taxes$1.89M-$63.18M$2.6M$18.19M$15.99M$27.41M$134.6M-$57.8M
Income taxes$2.63M$186.62M$763K$3.7M-$1.09M$6.29M$27.09M-$21.7M
Net income-$742K-$249.8M$1.84M$14.49M$17.08M$21.12M$107.52M-$36.11M
Net income attributable to common shareholders-$742K-$249.8M$1.84M$14.49M$17.08M$21.12M$107.52M-$36.11M
EBITDA$17.62M$32.21M$18.21M$36.16M$33.73M$43.83M$29.42M$9.24M
Basic earnings per share-$0.02-$5.14$0.04$0.30$0.35$0.43$2.16-$0.73
Diluted earnings per share-$0.02-$5.14$0.04$0.28$0.34$0.43$2.14-$0.73

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Nu Skin Enterprises (NUS) Q3 Earnings and Revenues Lag Estimates

Nu Skin Enterprises reported quarterly earnings of $0.10 per share, missing consensus estimates of $0.21 and falling 71% year-over-year. Revenue also missed expectations at $311.01 million versus $364.21 million a year ago. The stock has declined 48.1% year-to-date and received a Zacks Rank #3 (Hold) rating. Laird Superfood is expected to report results on November 12 with anticipated break-even earnings and significant revenue growth of 239.5% year-over-year.

Zacks Investment Research

e.l.f. Beauty (ELF) Tops Q2 Earnings and Revenue Estimates

e.l.f. Beauty reported quarterly earnings of $1.21 per share, significantly beating the consensus estimate of $0.62 per share, representing a 95.16% earnings surprise. The company also exceeded revenue expectations with $520.82 million, up 51.3% year-over-year. With a Zacks Rank #1 (Strong Buy) rating and the stock up 46.6% year-to-date, the cosmetics industry is performing well, ranking in the top 17% of industries. In contrast, Nu Skin Enterprises is expected to report declining earnings and revenues.

The Motley Fool

Why Nu Skin Enterprises Stock Flopped on Friday

Nu Skin Enterprises (NUS) shares fell over 3% after the company reported a 12% year-over-year decline in Q2 revenue and a steep drop in non-GAAP net income, despite beating analyst estimates. The company provided guidance for Q3 and full-year 2024, but the earnings forecast fell short of expectations.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily
Declared upcoming dividend $0.06 per share
Declared
Nov 5, 2026
Ex-dividend
Nov 27, 2026
Pay date
Dec 9, 2026
Ex-dividendAmount / sharePay dateType
Aug 28, 2026$0.06Sep 9, 2026recurring
May 29, 2026$0.06Jun 10, 2026recurring
Feb 27, 2026$0.06Mar 11, 2026recurring
Nov 28, 2025$0.06Dec 10, 2025recurring
Aug 29, 2025$0.06Sep 10, 2025recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.